| Literature DB >> 33309205 |
Marie-Madeleine Dolmans1, Jacques Donnez2, Luciana Cacciottola3.
Abstract
Cancer treatments are increasingly effective, but can result in iatrogenic premature ovarian insufficiency. Ovarian tissue cryopreservation is the only option available to preserve fertility in prepubertal girls and young women who require immediate chemotherapy. Ovarian tissue transplantation has been shown to restore hormonal cycles and fertility, but a large proportion of the follicle reserve is lost as a consequence of exposure to hypoxia. Another crucial concern is the risk of reimplanting malignant cells together with the grafted tissue. In this review, the authors advance some challenging propositions, from prevention of chemotherapy-related gonadotoxicity to ovarian tissue cryopreservation and transplantation, including the artificial ovary approach.Entities:
Keywords: chemotherapy; fertility preservation; ovarian reserve; ovarian tissue cryopreservation; transplantation
Mesh:
Substances:
Year: 2020 PMID: 33309205 DOI: 10.1016/j.molmed.2020.11.003
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951